A new era of preventative healthcare may be on the horizon, thanks to a large-scale study analyzing blood samples from half a million participants in the UK Biobank. Researchers have successfully mapped complete metabolic profiles, identifying potential biomarkers that could predict the onset of serious illnesses-like heart disease, cancer, and dementia-up to a decade before symptoms manifest.this breakthrough, utilizing data collected since 2006, promises to shift medical focus from reactive treatment to proactive prevention, offering individuals the opportunity to take control of their health through early intervention.
A groundbreaking global study analyzing key substances in blood has paved the way for a new generation of tests that could detect early signs of disease more than a decade before symptoms appear, researchers say.
The development of these predictive tests follows the completion of a major project by the UK Biobank, which measured levels of nearly 250 proteins, sugars, fats, and other compounds in blood samples collected from half a million volunteers. This research represents a significant step forward in preventative healthcare, offering the potential to shift the focus from treating illness to preventing it.
These complex molecular profiles provide a detailed snapshot of an individual’s physiology. When combined with medical records and death registries, scientists can now predict the risk of a range of conditions, including diabetes, heart disease, cancer, and dementia.
“This will be a real game-changer for our work,” said Dr. Joy Edwards-Hicks of the University of Edinburgh, who studies how changes in blood metabolites affect the immune system. “We are moving towards a model of prevention, where a simple blood sample – taken with a finger prick – can give us an idea of your health status.”
She added, “If we have early indicators of disease, we can tell a 40-year-old that their biomarkers don’t look good for their age and recommend changes they could make.”
The UK Biobank collaborated with Nightingale Health to measure hundreds of key metabolites in blood, including sugars, amino acids, fats, hormone precursors, and waste products like urea. These molecules are produced or used when the body breaks down food, drinks, and medications, and when organs use energy, repair damage, and build new tissues.
Changes in people’s metabolic profiles both reflect and drive the development of disease. When organs aren’t functioning properly, the profile shifts. A diseased liver can cause increased levels of ammonia. A compromised kidney can lead to higher levels of urea and creatinine. Muscle injury can be detected through increased lactate levels. And in the case of cancer, glucose uptake increases.
The picture scientists obtain from metabolic profiles is often more comprehensive than that provided by other tests. This is because metabolites are influenced not only by a person’s genetics but also by where and how they live – diet, exercise, exposure to pollution, and stress all play a role.
“These metabolic profiles capture all the genetic predispositions and the consequences of those, as well as exposures to environmental factors, giving us a holistic view of a person’s physiological state,” said Dr. Julian Mutz of King’s College London. “It’s also extremely dynamic, whereas genetics, for example, is fixed.”
Researchers have had some access to metabolic profiles through the UK Biobank previously, but having profiles for 500,000 volunteers means they can develop tests that detect early signs of disease more reliably and for a wider range of conditions.
Dr. Mutz is using metabolic profiles to predict the risk of dementia. If tests can reveal a higher risk 10-15 years in advance, doctors can intervene early to help patients reduce their chances of developing the condition. The new data is expected to accelerate progress in predicting rarer forms of neurodegenerative diseases, such as frontotemporal dementia.
Dr. Najaf Amin, a molecular epidemiologist, and other researchers at the University of Oxford have had early access to the 500,000 metabolic profiles. The data has already revealed differences in how men and women age and develop age-related diseases like cancer. “We will now delve deeper into the study of drug use in men and women,” she added. This research could clarify whether and how a person’s sex influences the effectiveness of certain medications.
The UK Biobank began recruiting volunteers in 2006. It allows scientists to find links between lifestyle, genetics, environment, and health by combining medical records, imaging, and now, a comprehensive set of metabolic profiles. “Studying metabolites is a powerful way to discover new warning signs, understand how diseases arise and evolve, and track the effectiveness of treatments,” said Prof. Naomi Allen, lead researcher at UK Biobank.
The above article is intended for your personal information only. If you represent a media outlet or company and wish to agree to republish our articles, please send an email to abonamente@news.ro.
